Skin sensitization assessments for chemicals, cosmetics, and many pharmaceuticals are required by regulatory bodies for hazard assessment and approval.
One of the main messages of the Global Summit on Regulatory Science (GSRS17) held in Brasilia in September was that decision-making about safety assessment is undergoing a major transition.
Edelweiss Connect has developed computer software that helps combine data from many different sources and formats into a useable form for evaluation and re-use. In addition, we have developed other software programs that can use the collected data and data from in vitro tests to predict the safety of chemical compounds in the human body.